Medulloblastoma and Cowden Syndrome
Further Evidence of an AssociationIn: Free Neuropathology, Jg. 311.1.2022SARS-CoV-2 vaccination induced cerebral venous sinus thrombosis
Do megakaryocytes, platelets and lipid mediators make up the orchestra?In: Free Neuropathology, Jg. 27.7.2021Neuropathology, my friend - on the paths of being and non-being
In: Free Neuropathology, Jg. 111.8.2020Deposits of disease-associated alpha-synuclein may be present in the dura mater in Lewy body disorders
implications for potential inadvertent transmission by surgeryIn: Free Neuropathology, Jg. 112.2.2020Hydrophilic polymer embolism identified in brain tumor specimens following Wada testing
A report of 2 casesIn: Free Neuropathology, Jg. 22.9.202161st Annual Meeting of the Canadian Association of Neuropathologists Association canadienne des neuropathologistes (CANP-ACNP) - Meeting Abstracts
In: Free Neuropathology, Jg. 229.10.2021Specific immune modulation of experimental colitis drives enteric alpha-synuclein accumulation and triggers age-related Parkinson-like brain pathology
In: Free Neuropathology, Jg. 218.5.2021Neuropathology of COVID-19 (neuro-COVID)
clinicopathological updateIn: Free Neuropathology, Jg. 218.1.2021Quantitative proteomic profiling of white matter in cases of cerebral amyloid angiopathy reveals upregulation of extracellular matrix proteins and clu [...]
In: Free Neuropathology, Jg. 18.10.2020Soluble brain homogenates from diverse human and mouse sources preferentially seed diffuse Aβ plaque pathology when injected into newborn mouse hosts
In: Free Neuropathology, Jg. 323.3.2022Neuropathology studies of dementia in US persons other than non-Hispanic whites
In: Free Neuropathology, Jg. 310.3.2022The Multifaceted Appearance of Supratentorial Ependymoma with ZFTA-MAML2 Fusion
In: Free Neuropathology, Jg. 220.9.2021Clustering of activated microglia occurs before the formation of dystrophic neurites in the evolution of Aβ plaques in Alzheimer’s disease.
In: Free Neuropathology, Jg. 14.8.2020Inhibiting the mitochondrial pyruvate carrier does not ameliorate synucleinopathy in the absence of inflammation or metabolic deficits
In: Free Neuropathology, Jg. 125.11.2020